New goods. New services. Barr Pharmaceuticals, Inc. http://10005.us.all.biz Sun, 26 Feb 2012 11:22:30 +0200 http://www.all.biz/img/logo.gif http://10005.us.all.biz http://www.us.all.biz/g161/ Duramed's ENJUVIA™ is an FDA approved once-daily oral estrogen therapy for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. A plant-derived formulation, ENJUVIA™ contains a blend of 10 synthetic estrogenic substances including . 8,9 . dehydroesterone sulfate (DHES). ENJUVIA™ tablets are available in a variety of dosage strengths including 0.3 mg, 0.45 mg, 0.625 mg and 1.25 mg. ENJUVIA™ uses a unique delivery system, consisting of Surelease technology with a cellulose-based polymer tablet design, to provide slow release of estrogens over several hours. The Company is detailing ENJUVIA™ to physicians in the United States using its 250-person Duramed Women’s Healthcare Sales Force. Marketing support includes professional education materials, published data from our clinical studies demonstrating the efficacy and safety of ENJUVIA™, and valuable patient information.]]> Fri, 29 Dec 2006 00:00:00 +0200 http://www.us.all.biz/g161/ http://www.us.all.biz/g163/ Plan B, which contains the synthetic progestin levonorgestrel, is an emergency oral contraceptive that can be used to prevent pregnancy following unprotected intercourse or contraceptive failure. To be effective, the product needs to be taken as soon as possible within 72-hours. On August 24, 2006 the FDA approved the Company’s application to market the Plan B emergency contraceptive Over-The-Counter (OTC) without a prescription. In approving the application, FDA granted OTC status for consumers 18 years of age and older, while maintaining the prescription status for women 17 and younger. The Company's Plan B OTC product and the prescription product will be marketed as a single package, which will allow for a prescription label to be adhered to the package when dispensed to women age 17 and younger. Because Plan B will still remain a prescription product for women 17 and younger, it will be sold in retail pharmacy outlets from behind the counter.]]> Fri, 29 Dec 2006 00:00:00 +0200 http://www.us.all.biz/g163/ http://www.us.all.biz/g165/ Oral contraceptives are the most common method of reversible birth control, used by up to 82% of women in the United States at some time during their reproductive years. Oral contraceptives have a long history with widespread use attributed to many factors including efficacy in preventing pregnancy, safety and simplicity in initiation and discontinuation, medical benefits and relatively low incidence of side effects. Barr manufactures and markets 22 generic oral contraceptive products as of the end of fiscal year 2005 (ended June 30, 2005) under trade names. Barr’s generic oral contraceptives compete with the branded versions of the products, and in most instances, with other generic products and/or authorized generic versions of the branded product.]]> Fri, 29 Dec 2006 00:00:00 +0200 http://www.us.all.biz/g165/ http://www.us.all.biz/g167/ Warfarin Sodium is the generic equivalent of Bristol-Myers Squibb's Coumadin®, an anticoagulant for patients with heart disease and/or high risk of stroke. Barr launched Warfarin Sodium in July 1997 and is presently one of three generic suppliers of the product.]]> Fri, 29 Dec 2006 00:00:00 +0200 http://www.us.all.biz/g167/